Skip to main content

Table 5 Multivariable regression analysis of patients with cancer to identify predictors of recurrent atrial fibrillation after a 90-day blanking period

From: Efficacy and safety of catheter ablation for atrial fibrillation in patients with history of cancer

Variables

OR (95% CI)

P value

Age

0.99 (0.94–1.03)

0.62

Female

1.23 (0.52–2.91)

0.64

BMI

1.08 (1.03–1.15)

0.002

Hypertension

0.25 (0.11–0.57)

0.001

Hyperlipemia

1.40 (0.64–3.09)

0.40

Diabetes

0.72 (0.25–1.97)

0.52

Obstructive sleep apnoea

0.82 (0.37–1.81)

0.63

Coronary artery disease

0.45 (0.15–1.26)

0.14

Paroxysmal atrial fibrillation

0.57 (0.27–1.21)

0.14

Long term persistent atrial fibrillation

1.11 (0.21–5.87)

0.90

CHA2DS2-VASc score

1.32 (0.97–1.83)

0.08

Pulmonary vein isolation plus lines

1.39 (0.68–2.85)

0.36

Cryoablation

1.09 (0.52–2.28)

0.82

Radiofrequency + Cryoablation

0.49 (0.10–2.06)

0.34

Anthracycline exposure

0.62 (0.24–1.54)

0.31

Thoracic radiation

0.37 (0.15–0.86)

0.02

Multiple malignancies

0.89 (0.32–2.31)

0.81

  1. BMI body mass index